Amaero, an Australian-listed producer of titanium and refractory metal powders for defense, aerospace and 3D printing applications, has revived its plans for a U.S. listing with a substantially reduced initial public offering. The company now intends to raise $20 million, down from its previous proposal of $53 million, as it revises the terms of its planned Nasdaq cross-listing following an earlier postponement attributed to adverse market conditions.

IPO Size Reduced by 62%

Amaero now plans to offer 3.9 million shares at an assumed price of $5.15 per share, based on the converted last reported trading price of its Australian Securities Exchange-listed securities.

The revised offering represents a significant reduction from the company’s previous proposal to raise up to $53 million by selling 7.5 million shares at $7.06 each. Under the new terms, expected proceeds are approximately 62% lower, while the company’s fully diluted market value would be approximately $143 million, a decline of 35% compared with the previous proposed terms. The company has not determined the timing of the IPO.

Second Attempt at a Nasdaq Listing

Amaero, which trades on the Australian Securities Exchange under the symbol 3DA, previously pursued a Nasdaq cross-listing in September 2026. The company subsequently postponed the offering, citing adverse market conditions.

The latest SEC filing signals a renewed effort to access U.S. capital markets with a smaller transaction and a lower assumed share price. The revised structure reduces the amount of capital Amaero expects to raise while also lowering the proposed valuation.

Titanium and Refractory Metal Powder Production

Amaero produces spherical titanium and refractory metal alloy powders for additive manufacturing, alongside large near-net-shape components manufactured using powder metallurgy hot isostatic pressing.

Its materials portfolio includes niobium, tungsten, tantalum, molybdenum, rhenium and titanium alloys. These materials are engineered for demanding applications in 3D-printed components used in hypersonic weapons systems, satellite propulsion, strategic missiles, aerospace and medical markets.

The company’s specialized materials focus places it within the advanced manufacturing supply chain, serving applications that require engineered metal powders and components.

Financial Profile and Nasdaq Listing Details

Founded in 2013, Amaero is based in McDonald, Tennessee, and generated approximately $12 million in revenue for the 12 months ended June 30, 2026.

The company plans to list on the Nasdaq under the symbol AMRO. Baird and Lake Street Capital Markets are serving as joint bookrunners for the offering. Stifel, previously listed as lead manager, is no longer identified as an underwriter in the revised filing.

Market Context & Opportunities

Amaero’s materials and manufacturing technologies serve specialized markets across defense, aerospace and medical applications. Its titanium and refractory metal powders are designed for additive manufacturing, while its powder metallurgy capabilities support the production of large, near-net-shape components.

A U.S. listing could provide greater access to American investors and potentially increase the company’s visibility among investors interested in advanced manufacturing and defense-related technologies. The revised offering, however, reflects a more conservative fundraising target than the company’s earlier proposal.

Risks & Challenges

The reduction in Amaero’s planned IPO size highlights the challenges of executing a cross-listing during unfavorable market conditions. The proposed fully diluted market value has also fallen substantially compared with the earlier terms.

Amaero’s reported $12 million in trailing revenue provides an indication of its current operating scale, but the company faces the execution challenges associated with specialized manufacturing, production expansion and serving demanding end markets. The final IPO terms and timing remain subject to further developments.

Closing Paragraph

Amaero has revived its Nasdaq listing plans with a $20 million IPO, cutting its expected proceeds by approximately 62% from its earlier $53 million proposal. With a focus on titanium and refractory metal powders for additive manufacturing and applications spanning defense, aerospace and medicine, the company is pursuing a revised route into U.S. capital markets after postponing its previous offering.